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Background: A growing literature has used differential rates of clinical outcomes and cardiovascular procedures as an indicator of potential 
inequalities in the health care system especially in vulnerable groups. Patients with Schizophrenia pose unique challenges due to affect, cognition, 
and socio-demographic factors. This study examines the outcomes of Acute Myocardial Infarction (AMI) in patients with Schizophrenia.
Methods: Using Nationwide Inpatient Sample (NIS) 2000-08, patients >18 years with a primary discharge diagnosis of AMI and any diagnosis of 
Schizophrenia were identified through appropriate validated ICD-9-CM codes. Outcomes were in-hospital mortality, length of stay (LOS) and receipt 
of revascularization procedures.
Results: Of 1,196,698 discharges with AMI 4,648 had diagnosed Schizophrenia. Patients with Schizophrenia presenting with AMI compared with 
remainder of the sample were younger (63.3±14 vs. 67.6±14 years), less likely male (53% vs. 59.8%), more likely diabetic (36.1% vs. 29.7%) and 
had higher charlson score (2.1±1.3 vs. 1.9±1.3) (all p<0.001). Patients with Schizophrenia had higher mortality (7.9 % vs. 6.2%), longer LOS (6.8 vs 
5.3 days) and lower rates of percutaneous coronary intervention (PCI) (21.2% vs. 34.1%) and coronary artery bypass grafting (CABG) (5.5% vs. 8.3%) 
(all p<0.001). On multivariate analysis, Schizophrenia independently predicted increased mortality [Odds ratio (OR) 1.47, p<0.001] and patients 
with Schizophrenia were more likely to be medically managed (OR 2.11, p<0.001). There was no difference in the adjusted mortality between 
patients with and without Schizophrenia who underwent thrombolysis (p=0.35), PCI (p=0.95) or CABG (p=0.11).
Conclusion: Using nationally representative data, this study shows that the in-hospital mortality and LOS of AMI in patients with Schizophrenia 
is higher and they are less likely to receive revascularization procedures. The outcome when they do receive coronary interventions is similar to the 
general population. Further research is needed to understand the degree to which patient and provider factors contribute to this disparity and its 
implications for quality and long-term outcomes of care.
